NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND)

CompletedN/A

Sponsor: AstraZeneca

Conditions: COPD

Countries: Japan

This retrospective observational study aims to report distribution of the proportion of symptomatic Chronic obstructive pulmonary disease (COPD) patients classified by the COPD Assessment Test (CAT) managed with single or dual inhaler treatment using the data at cohort entry in the COPD cohort study, and treatment change and longitudinal CAT score by each inhaler treatment will also be evaluated using the data during the follow-up period.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients taken with any of following inhaler treatments; LAMA, LAMA+LABA(both single and dual inhaler) or ICS+LABA(both single and dual inhaler) at cohort entry

Exclusion Criteria:

* Patients enrolled at the sites participated in the COPD cohort study where not agreed on secondary use of data for this study

Locations (1)

Osaka, Japan